Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-25-013902
Filing Date
2025-04-30
Accepted
2025-04-30 17:08:52
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A omer20241231_10ka.htm   iXBRL 10-K/A 644795
2 EXHIBIT 31.3 ex_804604.htm EX-31.3 3930
3 EXHIBIT 31.4 ex_804621.htm EX-31.4 3665
  Complete submission text file 0001437749-25-013902.txt   989602

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA omer-20241231.xsd EX-101.SCH 5650
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20241231_def.xml EX-101.DEF 17760
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20241231_lab.xml EX-101.LAB 42408
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20241231_pre.xml EX-101.PRE 22646
21 EXTRACTED XBRL INSTANCE DOCUMENT omer20241231_10ka_htm.xml XML 10839
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34475 | Film No.: 25897365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)